BlackRock
SGNT

BlackRock’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

BlackRock’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,116
Closed -$196K – 3815
2016
Q2 		$196K Buy
13,116
+11,607
+769% +$149K ﹤0.01% 2118
2016
Q1 		$18K Buy
1,509
+887
+143% +$12.4K ﹤0.01% 2911
2015
Q4 		$10K Hold
622
– – ﹤0.01% 2914
2015
Q3 		$10K Hold
622
– – ﹤0.01% 2749
2015
Q2 		$15K Hold
622
– – ﹤0.01% 2568
2015
Q1 		$14K Sell
622
-212
-25% -$5.61K ﹤0.01% 2569
2014
Q4 		$21K Buy
834
+212
+34% +$6.22K ﹤0.01% 2362
2014
Q3 		$19K Hold
622
– – ﹤0.01% 2380
2014
Q2 		$16K Buy
622
+80
+15% +$1.78K ﹤0.01% 2519
2014
Q1 		$12K Hold
542
– – ﹤0.01% 2639
2013
Q4 		$14K Hold
542
– – ﹤0.01% 2549
2013
Q3 		$11K Hold
542
– – ﹤0.01% 2617
2013
Q2 		$11K Buy
+542
New +$9.69K ﹤0.01% 2622

BlackRock's SGNT Position: Q3 2016 in Review

BlackRock sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 13,116 shares — an estimated $196K sold.

BlackRock first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $196K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • BlackRock reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • BlackRock sold 13,116 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $196K.
  • BlackRock first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • BlackRock's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $196K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on BlackRock's 13F filing for Q3 2016, filed 8 Nov 2016.